Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | Director | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,900 |
Reported balance
After 2026-09-10 transaction · row 1
1 source rowRow 1 · 2026-09-10 · Disposition to issuer · Disposed 6,000 · Balance 33,900 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Disposition to issuerCommon Stock | 6,000 | $26.82 | $160,920.00 |
DisclosureSEC source: 0001193125-26-390731 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,900 Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 472 | $26.50 | $12,508.00 |
DisclosureSEC source: 0001193125-26-352527 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,900 F1 · kind: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:43 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 7,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-217253 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,428 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 10,000 | $21.65 | $216,500.00 |
DisclosureSEC source: 0001193125-25-274502 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,232 F1 · price: The price reported in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $21.51 to $21.76 for a weighted average sales price of $21.65. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2025 Filed May 12, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 11,427 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-069434 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,232 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 8, 2026. Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 7,000 | $11.16 | $78,120.00 |
DisclosureSEC source: 0000950170-24-101930 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,805 F1 · price: The price reported in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $11.16 to $11.18 for a weighted average sales price of $11.16. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. Read SEC document |
| May 09, 2024 Filed May 13, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 18,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-058788 · ownership.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,805 F1 · kind: Restricted shares granted pursupant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 9, 2025. Read SEC document |
| May 11, 2023 Filed May 15, 2023 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 10,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029511 · doc4.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,445 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 11, 2024. Read SEC document |
| May 12, 2022 Filed May 13, 2022 21:04 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 8,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028907 · doc4.xml · nonDerivative · entry 1 Linynsky Laura A · CIK 0001543891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,480 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.